Cited by 57Liver physiology and pathologyLiver Disease and TransplantationImmune cells in cancer

Liver stromal cells restrict macrophage maturation and stromal IL-6 limits the differentiation of cirrhosis-linked macrophages

Buonomo, Erica L., Mei, Shenglin, Guinn, Samantha R., Leo, Isabelle R., Peluso, Michael J., Nolan, Mei-An, Schildberg, Frank A., Zhao, Lei +5 more·2022·Journal of Hepatology

Abstract

Background & aims Myeloid cells are key regulators of cirrhosis, a major cause of mortality worldwide. Because stromal cells can modulate the functionality of myeloid cells in vitro, targeting stromal-myeloid interactions has become an attractive potential therapeutic strategy. We aimed to investigate how human liver stromal cells impact myeloid cell properties and to understand the utility of a stromal-myeloid coculture system to study these interactions in the context of cirrhosis. Methods Single-cell RNA-sequencing analyses of non-cirrhotic (n = 7) and cirrhotic (n = 5) human liver tissue were correlated to the bulk RNA-sequencing results of in vitro cocultured human CD14 + and primary liver stromal cells. Complimentary mechanistic experiments and flow cytometric analysis were performed on human liver stromal-myeloid coculture systems. Results We found that stromal-myeloid coculture reduces the frequency CD14 + cell subsets transcriptionally similar to liver macrophages, showing that stromal cells inhibit the maturation of monocytes into macrophages. Stromal cells also influenced in vitro macrophage differentiation by skewing away from cirrhosis-linked CD9 + scar-associated macrophage-like cells and towards CD163 + Kupffer cell-like macrophages. We identify IL-6 production as a mechanism by which stromal cells limit CD9 + macrophage differentiation and find that local IL-6 levels are decreased in early-stage human liver disease compared to healthy liver tissue, suggesting…

Integrity signals

Registry

Crossref · 10.1016/j.jhep.2021.12.036

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Local IL-6 level is decreased in early-stage human liver diseases compared to healthy liver tissues, suggesting a protective role for local IL-6 in the healthy liver.

    “Additionally, local IL-6 level is decreased in early-stage human liver diseases as compared to healthy liver tissues, suggesting a protective role for local IL-6 in the healthy liver [78].”
  • The gp130 protein is widely expressed in tissues, representing extensive responses to IL-6 via trans-signaling activated by the IL-6/sIL-6R/gp130 complex.

    “However, the gp130 protein is widely expressed in tissues [78], representing the extensive responses to IL-6 via the trans-signaling activated by IL-6/sIL-6R/gp130 complex.”

No citation lists for this paper

No citation lists for this paper yet — checked again daily.

References 24 · Cited by 57

Authors
Buonomo, E. L., Mei, S., Guinn, S. R., Leo, I. R., Peluso, M. J., Nolan, M.-A., Schildberg, F. A., Zhao, L., Lian, C., Xu, S., Misdraji, J., Kharchenko, P. V., & Sharpe, A. H.
Affiliations
  • Brigham and Women's Hospital (US)
  • Harvard University (US)
  • University Hospital Bonn (DE)
Corresponding author
Sharpe, Arlene H.
Venue
Journal of Hepatology
Publisher
Elsevier BV
Published
2022-05
Volume
76
Issue
5
Pages
1127-1137
ISSN
0168-8278 (ISSN-L)
OpenAlex
W4206273452
Cited by
57
References
24
Citations by year
2026: 10 · 2025: 19 · 2024: 15 · 2023: 12 · 2022: 1
FWCI
6.99
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Hepatology (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Cancer Institute (T32CA207021)
Topics
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
Keywords
liver cirrhosis, macrophage maturation, interleukin-6, Kupffer cells, CD14+ monocytes, CD163+ macrophages, liver disease, macrophage differentiation, co-culture, single-cell RNA sequencing
MeSH terms
Cell Differentiation, Humans, Liver Cirrhosis, Liver Diseases, Macrophages, Monocytes, RNA, Interleukin-6, Stromal Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review